Inici › Sobrepès › Indiana › Indianapolis
Assaigs clínics de Sobrepès a Indianapolis, IN
13 estudis de Sobrepès busquen participants en centres de Indianapolis i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
ReclutantFase 3
- IU Health - Riley Physicians Endo-Diab, Indianapolis
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
ReclutantFase 3
- Midwest Inst For Clin Res, Indianapolis
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
ReclutantFase 3
- Midwest Inst For Clin Res, Indianapolis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ReclutantFase 3
- Indiana University Health University Hospital, Indianapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
ReclutantFase 3
- Riley Hospital for Children, Indianapolis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
ReclutantFase 3
- Indiana University Health University Hospital, Indianapolis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutantFase 3
- DM Clinical Research - Indianapolis, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
ReclutantFase 3
- AURORA-1 Clinical Site, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutantFase 3
- AURORA-2 Clinical Site, Indianapolis
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
ReclutantFase 2
- Investigators Research Group, Brownsburg · a 14 mi
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
ReclutantFase 4
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · a 14 mi
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
ReclutantFase 3
- Midwest Inst For Clin Res, Indianapolis
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Reclutant
- Indiana University, Indianapolis
Assaigs de Sobrepès en altres ciutats
- San Antonio, TX34 estudis
- Houston, TX33 estudis
- Chicago, IL28 estudis
- Orlando, FL27 estudis
- Las Vegas, NV23 estudis
- Miami, FL23 estudis
- Atlanta, GA20 estudis
- Dallas, TX20 estudis
- New York City, NY19 estudis
- Jacksonville, FL19 estudis
- Washington, DC19 estudis
- Austin, TX18 estudis
Altres estudis a Indianapolis
- Càncer de pulmó de cèl·lules no petites32 estudis
- Càncer (tots els tipus)24 estudis
- Insuficiència cardíaca23 estudis
- Càncer de mama20 estudis
- Obesitat20 estudis
- Càncer metastàtic19 estudis
- Càncer colorrectal18 estudis
- Càncer d'ovari17 estudis
- Càncer de pulmó16 estudis
- Malaltia cardiovascular16 estudis
- Diabetis tipus 114 estudis
- Càncer d'endometri14 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.